Replies to post #241337 on Biotech Values

[DewDiligence]

TYME seeks reverse-merger partner:

https://finance.yahoo.com/news/tyme-technologies-inc-announces-exploration-105000969.html

The PR doesn’t actually say that, but it may as well have. TYME has $92M of cash (as of 12/31/21) and nothing of consequence in the clinic following the failure of SM-88 in pancreatic cancer two months ago (#msg-167645887).